Treatment of viral hepatitis includes acute treatment and general treatment.

① Treatment of acute phase.

Patients with clinical symptoms of gastrointestinal bleeding should take emergency management.

Vasoactive medications such as vasopressin, octreotide, somatostatin, and terisopressin should be given as soon as possible when bleeding due to gastroesophageal varices occurs. If drugs are ineffective after these treatments, patients should be treated with sclerosing agent injection and ligation under endoscope. Intrahepatic portal vein shunt surgery, such as jugular intrahepatic portal vein stent shunt, balloon compression to stop bleeding or reduce vascular pressure, can also be selected.

② General treatment.

Generally treated patients can choose adequate rest to achieve the purpose of treatment. Viral hepatitis patient should choose to rest in bed when the symptom is apparent or the condition is serious, because the posture of bed can increase the amount of blood flowing through the liver, have certain help to the body to restore health, and the patient with lighter viral hepatitis can choose to have a few lighter activities. At the same time, in daily diet to achieve reasonable collocation, avoid drinking, eat more high-protein, high-vitamin, digestible and high-calorie food, it should be noted that patients do not deliberately eat some high-nutritional food is necessary, because to avoid the occurrence of fatty liver caused by excess nutrition.

In terms of drug therapy, there is no absolute best, best or most effective medication due to the great individual difference of each patient. In addition to commonly used over-the-counter drugs, other drugs should be selected according to individual conditions under the guidance of doctors.

For the antiviral treatment of viral hepatitis, the drugs selected are drugs that can inhibit the replication of the virus, can reduce the infectivity of the virus and improve the liver function of patients, reduce the liver lesions, delay or reduce liver hardening, failure. It should be noted that antiviral therapy should be determined by the doctor based on the patient’s comprehensive situation.

Interferon is commonly used for the treatment of chronic hepatitis B and C, but is not recommended for women with serum bilirubin levels more than twice normal, with autoimmune disease, decompensated cirrhosis, with vital organ disease, and women of childbearing age. After using interferon soy platelets and granulocyte bone marrow suppression phenomenon appears the possibility, also can have the possibility of abnormal mental nerve, because this kind of interferon medicine needs to fall in the doctor’s guidance, let the doctor decide to reduce medicine or stop medicine through the patient’s situation observation.

Nucleoside analogues are a class of drugs that can be used for the treatment of hepatitis B. Biochemical indexes of patients need to be checked before and during treatment, as well as viral load and virological markers. Patients need to be followed up for at least 12 months after stopping the drug to determine the status of their condition.